Evidence map›Paper›PMID 31586162›Full record

ArticleNature protocols2019

The isolation and molecular characterization of cerebral microvessels.

Yun-Kyoung Lee, Hiroki Uchida, Helen Smith, Akira Ito, Teresa Sanchez

Open access · greenAbstract read
In one paragraph

Article in Nature protocols, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 191 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. NF-Frontiers in cardiovascular medicine · 2026
    Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yun-Kyoung LeeDepartment of Pathology and Laboratory Medicine, Center for Vascular Biology, Weill Cornell Medicine, New York, NY, USA.
Hiroki UchidaDepartment of Pathology and Laboratory Medicine, Center for Vascular Biology, Weill Cornell Medicine, New York, NY, USA.
Helen SmithDepartment of Pathology and Laboratory Medicine, Center for Vascular Biology, Weill Cornell Medicine, New York, NY, USA.
Akira ItoDepartment of Pathology and Laboratory Medicine, Center for Vascular Biology, Weill Cornell Medicine, New York, NY, USA.
Teresa SanchezDepartment of Pathology and Laboratory Medicine, Center for Vascular Biology, Weill Cornell Medicine, New York, NY, USA. tes2015@med.cornell.edu.ORCID http://orcid.org/0000-0002-2711-7423
Cornell University · US

Funding

Endothelial Sphingolipid Signaling in Post-Sepsis Cognitive Impairment.R01NS114561 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI SANCHEZ GARCIA-VAO, TERESA · 2020 to 2024
$2.4M
Sphingolipid Signaling in Endothelial Responses to InjuryR01HL094465 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SANCHEZ GARCIA-VAO, TERESA · 2009 to 2013
$2.1M
NHLBI NIH HHS R01 HL094465NINDS NIH HHS R01 NS114561
6 · The paper itself

Abstract

The study of cerebral microvessels is becoming increasingly important in a wide variety of conditions, such as stroke, sepsis, traumatic brain injury and neurodegenerative diseases. However, the molecular mechanisms underlying cerebral microvascular dysfunction in these conditions are largely unknown. The molecular characterization of cerebral microvessels in experimental disease models has been hindered by the lack of a standardized method to reproducibly isolate intact cerebral microvessels with consistent cellular compositions and without the use of enzymatic digestion, which causes undesirable molecular and metabolic changes. Herein, we describe an optimized protocol for microvessel isolation from mouse brain cortex that yields microvessel fragments with consistent populations of discrete blood-brain barrier (BBB) components (endothelial cells, pericytes and astrocyte end feet) while retaining high RNA integrity and protein post-translational modifications (e.g., phosphorylation). We demonstrate that this protocol allows the quantification of changes in gene expression in a disease model (stroke) and the activation of signaling pathways in mice subjected to drug administration in vivo. We also describe the isolation of genomic DNA (gDNA) and bisulfite treatment for the assessment of DNA methylation, as well as the optimization of chromatin extraction and shearing from cortical microvessels. This optimized protocol and the described applications should improve the understanding of the molecular mechanisms governing cerebral microvascular dysfunction, which may help in the development of novel therapies for stroke and other neurologic conditions.

Indexed as

AnimalsAstrocytesBlood-Brain BarrierBrainBrain ChemistryDNAEndothelial CellsMiceMice, Inbred C57BLMice, TransgenicMicrovesselsPericytesRNADNARNA

Identifiers

PMID31586162
PMCPMC11571963
OpenAlexW2979187841

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.